Whalegun
Lobbying

Epigenomics's latest lobbying report covers Q1 2023, at under $5,000. Its first report covers Q2 2022; the issues it reports most are Health Issues.

Epigenomics

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q2 2022
The first quarter a report named it

Lobbying by quarter

Epigenomics lobbying by quarter
Epigenomics lobbying by quarter
QuarterAmountReports
Q2 2022$90K2
Q3 2022$30K1
Q4 2022$130K3
Q1 2023$01
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$250K · 6 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE5 reports
  • Health & Human Services, Dept of (HHS)3 reports

Firms it paid

Firm
BGR Government Affairs$110K3 quarters
Meridian Hill Strategies Formerly Known As "ernest C. Baynard Iv"$90K3 quarters
Stewart Strategies and Solutions$50K1 quarters

Former officials lobbying for it

Former position
DANIEL FARMERSee prior filingQ4 2022
JOEL D. BAILEYSee prior filingQ4 2022
JONATHAN MANTZSee prior filingQ4 2022
REMY LEIGH BRIM MASONSee prior filingQ4 2022
ROBB WALTONSee prior filingQ4 2022
ROBERT WOODSee prior filingQ4 2022

Lobbying reports

Filed by
23/05/10for Q2 2022BGR Government Affairs$60K
23/04/20for Q1 2023BGR Government AffairsUnder $5,000
23/02/15for Q4 2022Meridian Hill Strategies Formerly Known As "ernest C. Baynard Iv"$30K
23/02/15for Q4 2022Meridian Hill Strategies Formerly Known As "ernest C. Baynard Iv"$30K
23/02/15for Q3 2022Meridian Hill Strategies Formerly Known As "ernest C. Baynard Iv"$30K
23/02/15for Q2 2022Meridian Hill Strategies Formerly Known As "ernest C. Baynard Iv"$30K
23/01/20for Q4 2022BGR Government Affairs$50K
23/01/20for Q4 2022Stewart Strategies and Solutions$50K